# CRISPR Gene Therapy Keeps All 45 Sickle Cell Patients Crisis-Free at 2 Years - Date: 2026-03-12 All 45 patients treated with the first FDA-approved CRISPR gene therapy remain free of sickle cell crises two years after treatment, according to data presented Sunday at the American Society of Hematology meeting in San Diego. The results mark the strongest durability signal yet for exagamgloge... ---